Changes in metabolic parameters following a switch to aripiprazole in Japanese patients with schizophrenia: One-year follow-up study

Hiroyoshi Takeuchi, Hiroyuki Uchida, Takefumi Suzuki, Koichiro Watanabe, Haruo Kashima

Research output: Contribution to journalArticlepeer-review

19 Citations (Scopus)

Abstract

The purpose of the present study was to evaluate changes in metabolic parameters after switching to aripiprazole in Japanese population. In this 1-year observation study, following a switch to aripiprazole, 32 patients with schizophrenia were observed and assessment was done of bodyweight, total cholesterol, triglyceride, serum prolactin level, and corrected QT (QTc) interval. Significant reductions were observed in these parameters other than QTc interval. Given known detrimental metabolic and hormonal effects of some atypical antipsychotics, a switch to aripiprazole may warrant serious consideration also in Asian patients who suffer those side-effects.

Original languageEnglish
Pages (from-to)104-106
Number of pages3
JournalPsychiatry and Clinical Neurosciences
Volume64
Issue number1
DOIs
Publication statusPublished - 2010 Feb 1

Keywords

  • Antipsychotics
  • Aripiprazole
  • Metabolic
  • Side-effect

ASJC Scopus subject areas

  • Neuroscience(all)
  • Neurology
  • Clinical Neurology
  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Changes in metabolic parameters following a switch to aripiprazole in Japanese patients with schizophrenia: One-year follow-up study'. Together they form a unique fingerprint.

Cite this